Skip to main content
Clinical Trials/NCT05717959
NCT05717959UnknownNot Applicable

Efficacy of Oropharyngeal Exercises for Patients With Obstructive Sleep Apnea Using Mandibular Advancement Device

National Cheng-Kung University Hospital1 site in 1 country20 target enrollmentStarted: September 2, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
20
Locations
1
Primary Endpoint
Apnea-hypopnea -index

Study Overview

Brief Summary

Combined treatment with MAD and OE for adult patients with obstructive sleep apnea can significantly (i) improve muscle strength and endurance; (ii) reduce the severity of sleep apnea.

Detailed Description

Background: Obstructive Sleep Apnea (OSA) is a sleeping disorder with recurrent upper airway obstruction during sleep. Patients with OSA often suffer from daytime sleepiness, snoring, and interrupted breathing during sleep. The etiology of OSA can divide into anatomical causes, including narrow, crowded, or easily collapsible upper airway, and non-anatomical causes, including low respiratory arousal threshold, ineffective or reduced pharyngeal dilator muscle activity during sleep, and unstable ventilatory control. A mandibular advancement device (MAD) is one of the treatment options for mild to moderate OSA patients. Oropharyngeal exercises (OE) are a novel intervention targeted at internal/external tongue muscle training with significant improvements in the muscle tension and severity of OSA. The efficacy of combined treatment with MAD and OE has not been investigated. Thus, the present study aims to determine the effectiveness of combing MAD and OE by assessing the tongue function and severity of OSA in patients with OSA.

Methods: A total of 20 participants using MAD for OSA were included in the study. Participants will be divided into two groups: the treatment group with the 12-week OE. OE consists of one to three times 30-minute sessions per day, 3 to 5 days per week for 12 weeks. The weekly clinic visits are required to adjust the intensity of the home exercise program and monitor the training progress. The participants in two groups will receive polysomnography (PSG) test, tongue muscle strength, and endurance testing, at baseline and after the intervention.

Expected results: Combined treatment with MAD and OE for adult patients with mild to moderate obstructive sleep apnea can significantly (i) improve muscle strength and endurance; (ii) reduce the severity of sleep apnea

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
20 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •OSA patients
  • •aged over 20 years old
  • •wearing a MAD

Exclusion Criteria

  • •Body Mass Index (BMI) ≧ 35
  • •Pregnancy
  • •Severe obstructive or restrictive lung disease
  • •Exercise with high-risk cardiovascular disease
  • •History of central or peripheral neurological disease resulting in an inability to perform exercise prescriptions
  • •Musculoskeletal or psychological disorders that prevent the performance of exercise prescriptions
  • •Chronic illnesses that are ongoing or not yet controlled

Arms & Interventions

intervention group

Experimental

We conducted a once a week, 12-week-intervention of Oropharyngeal Exercises and Mandibular advancement device

Intervention: Oropharyngeal Exercises (Behavioral)

control group

Sham Comparator

Mandibular advancement device

Intervention: Oropharyngeal Exercises (Behavioral)

Outcomes

Primary Outcomes

Apnea-hypopnea -index

Time Frame: Baseline to 12 weeks

Assessed using Polysomnography (PSG). The average apnea and hypopnea events per hour, oxygen saturation index and the snoring index will be obtained during the sleep test(PSG)

Secondary Outcomes

  • Tongue muscle endurance(Baseline to 12 weeks)
  • Tongue muscle strength(Baseline to 12 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials